Product image of Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride) supplied by GNH India

Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited

Active Ingredient:
Tetracaine Hydrochloride
Origin:
EU

Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited, is a local anesthetic presented as an ophthalmic solution for ocular use. It produces rapid, reversible surface anesthesia, facilitating diagnostic eye examinations, foreign‑body removal, laser procedures and pre‑operative preparation in patients of all ages.

GNH India supplies Minims Tetracaine Chlorhydrate Bausch + Lomb Ireland Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for ophthalmic care.

Manufacturer / TM Owner

Bausch + Lomb Ireland Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Tetracaine Hydrochloride is a topical ocular anesthetic used to numb the surface of the eye.

  • Diagnostic ocular examinations: provides temporary anesthesia to allow thorough assessment without patient discomfort.
  • Minor eye procedures: facilitates foreign‑body removal, laser treatment and other minor interventions by numbing the ocular surface.
  • Pre‑operative ocular surgery: delivers pre‑operative anesthesia to prepare the eye for surgical procedures.

How It Works

  • Tetracaine Hydrochloride acts by reversibly blocking voltage‑gated sodium channels on ocular nerve fibers, inhibiting the initiation and propagation of nerve impulses. This blockade prevents the transmission of pain signals from the cornea and conjunctiva, resulting in rapid loss of sensation in the treated area while preserving other ocular functions.

Side Effects

Tetracaine Hydrochloride may cause a range of ocular reactions.

Common Side Effects

  • Stinging or burning sensation at the application site.
  • Transient itching or irritation.
  • Conjunctival hyperemia (redness).
  • Excessive tearing.
  • Blurred vision lasting a few minutes.
  • Mild corneal epithelial irritation.

Serious or Rare Side Effects

  • Corneal epithelial toxicity or ulceration.
  • Severe allergic reaction (e.g., angio‑edema, anaphylaxis).
  • Persistent ocular inflammation.
  • Vision loss (rare).
  • Secondary infection due to compromised corneal integrity.

Precautions & Warnings

When using Tetracaine Hydrochloride, consider the following precautions.

  • Allergy assessment: verify no known hypersensitivity to ester‑type local anesthetics.
  • Professional supervision: administer only under the direction of qualified eye‑care personnel.
  • Corneal integrity: avoid use on eyes with existing epithelial defects or infections.
  • Frequency limitation: do not exceed the recommended number of applications within a 24‑hour period.
  • Systemic absorption: monitor patients with extensive ocular surface exposure for systemic effects.
  • Store at room temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Tetracaine Hydrochloride can interact with other ocular agents.

Major Interactions (Avoid)

  • Concurrent use of other topical ocular anesthetics: increased risk of cumulative corneal toxicity.
  • Contact lens wear during treatment: may enhance drug absorption and cause irritation.

Moderate Interactions (Monitor Closely)

  • Anticholinergic eye drops: possible alteration of pupil response.
  • Beta‑blocker ophthalmic solutions: monitor intra‑ocular pressure changes.
  • Systemic antiarrhythmic drugs: theoretical additive sodium‑channel blockade.
  • Topical corticosteroids: may mask early signs of corneal toxicity.

Frequently Asked Questions

Minims Tetracaine is used to provide short‑lasting topical anesthesia of the eye. It is applied before diagnostic examinations, minor procedures such as foreign‑body removal or laser treatment, and as a pre‑operative measure to numb the ocular surface for surgery.

Tetracaine Hydrochloride blocks voltage‑gated sodium channels in the sensory nerves of the cornea and conjunctiva. By preventing sodium influx, it stops the generation and propagation of pain signals, resulting in rapid, reversible loss of sensation on the eye’s surface.

The specific dose and frequency are determined by the prescribing eye‑care professional based on the procedure and patient needs. The prescriber will decide the number of drops and timing appropriate for each clinical situation.

Safety data for Tetracaine Hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minims Tetracaine belongs to the ester‑type local anesthetic class and provides rapid onset with a duration of 10‑20 minutes, similar to other agents like proparacaine. Compared with amide‑type anesthetics, it may have a slightly higher risk of corneal toxicity if overused, making careful dosing important.

Store the ophthalmic solution at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed in its original packaging to protect the formulation from contamination and degradation.

The solution is applied topically to the eye as one or more drops, as directed by the eye‑care professional. The patient should be instructed to avoid blinking excessively for a few seconds after instillation to allow adequate absorption.

Serious risks include corneal epithelial toxicity, severe allergic reactions such as angio‑edema, and rare cases of vision loss. Prompt medical attention is required if persistent pain, redness, visual changes, or signs of an allergic response occur.

Patients with known hypersensitivity to tetracaine or other ester‑type anesthetics, those with active corneal epithelial defects, infections, or severe ocular surface disease should avoid using this product. It should also be used with caution in individuals on systemic sodium‑channel‑blocking medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tetracaine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT